Literature DB >> 17668088

Mesoporous silica nanoparticle based controlled release, drug delivery, and biosensor systems.

Brian G Trewyn1, Supratim Giri, Igor I Slowing, Victor S-Y Lin.   

Abstract

Recent advancements in controlling the surface properties and particle morphology of the structurally defined mesoporous silica materials with high surface area (>700 m(2) g(-1)) and pore volume (>1 cm(3) g(-1)) have significantly enhanced their biocompatibility. Various methods have been developed for the functionalization of both the internal pore and exterior particle surfaces of these silicates with a tunable pore diameter ranging from 2 to 30 nm and a narrow pore size distribution. Herein, we review the recent research progress on the design of functional mesoporous silica materials for stimuli-responsive controlled release delivery of pharmaceutical drugs, genes, and other chemicals. Furthermore, the recent breakthroughs in utilizing these nanoscale porous materials as sensors for selective detections of various neurotransmitters and biological molecules are summarized.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17668088     DOI: 10.1039/b701744h

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  58 in total

1.  Stimulus-responsive controlled release system by covalent immobilization of an enzyme into mesoporous silica nanoparticles.

Authors:  Jessica Méndez; Alina Monteagudo; Kai Griebenow
Journal:  Bioconjug Chem       Date:  2012-03-13       Impact factor: 4.774

2.  Development of a new sensitive immunostrip assay based on mesoporous silica and colloidal Au nanoparticles.

Authors:  Kobra Omidfar; Behnosh Khorsand; Bagher Larijani
Journal:  Mol Biol Rep       Date:  2011-05-21       Impact factor: 2.316

3.  Nucleation and Assembly of Silica into Protein-Based Nanocomposites as Effective Anticancer Drug Carriers Using Self-Assembled Silk Protein Nanostructures as Biotemplates.

Authors:  Jie Wang; Shuxu Yang; Chenlin Li; Yungen Miao; Liangjun Zhu; Chuanbin Mao; Mingying Yang
Journal:  ACS Appl Mater Interfaces       Date:  2017-06-30       Impact factor: 9.229

4.  Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals.

Authors:  Jie Lu; Monty Liong; Zongxi Li; Jeffrey I Zink; Fuyuhiko Tamanoi
Journal:  Small       Date:  2010-08-16       Impact factor: 13.281

5.  Microfluidic Diatomite Analytical Devices for Illicit Drug Sensing with ppb-Level Sensitivity.

Authors:  Xianming Kong; Xinyuan Chong; Kenny Squire; Alan X Wang
Journal:  Sens Actuators B Chem       Date:  2017-12-16       Impact factor: 7.460

Review 6.  Intelligent design of multifunctional lipid-coated nanoparticle platforms for cancer therapy.

Authors:  Srinivas Ramishetti; Leaf Huang
Journal:  Ther Deliv       Date:  2012-12

7.  Involvement of lysosomal exocytosis in the excretion of mesoporous silica nanoparticles and enhancement of the drug delivery effect by exocytosis inhibition.

Authors:  Rolando E Yanes; Derrick Tarn; Angela A Hwang; Daniel P Ferris; Sean P Sherman; Courtney R Thomas; Jie Lu; April D Pyle; Jeffrey I Zink; Fuyuhiko Tamanoi
Journal:  Small       Date:  2012-11-14       Impact factor: 13.281

8.  The role of nonbonded interactions in the conformational dynamics of organophosphorous hydrolase adsorbed onto functionalized mesoporous silica surfaces.

Authors:  Diego E B Gomes; Roberto D Lins; Pedro G Pascutti; Chenghong Lei; Thereza A Soares
Journal:  J Phys Chem B       Date:  2010-01-14       Impact factor: 2.991

9.  Non-destructively shattered mesoporous silica for protein drug delivery.

Authors:  Chenghong Lei; Baowei Chen; Xiaolin Li; Wen Qi; Jun Liu
Journal:  Microporous Mesoporous Mater       Date:  2013-07-15       Impact factor: 5.455

10.  Silica nanoparticles as a delivery system for nucleic acid-based reagents.

Authors:  Christopher Hom; Jie Lu; Fuyuhiko Tamanoi
Journal:  J Mater Chem       Date:  2009-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.